Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum

被引:166
作者
Honda, H [1 ]
Miharu, N [1 ]
Ohashi, Y [1 ]
Samura, O [1 ]
Kinutani, M [1 ]
Hara, T [1 ]
Ohama, K [1 ]
机构
[1] Hiroshima Univ, Sch Med, Dept Obstet & Gynecol, Minami Ku, Hiroshima 7348551, Japan
关键词
D O I
10.1007/s00439-001-0649-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fetal DNA in maternal plasma and serum has been shown to be a useful material for fetal gender determination and for screening tests for abnormal pregnancies except during early gestational ages. Maternal serum samples were obtained from 81 pregnant women during the 5th-10th weeks of gestation. Fetal gender was determined by conventional polymerase chain reaction (PCR) to detect a Y-chromosomal sequence (DYS14) in maternal serum during early gestation and confirmed by examination of the newborns after delivery. Real-time quantitative analyses of the SRY and beta-globin genes were also performed in order to determine fetal gender and to quantify fetal DNA concentration in maternal serum during early gestation. When using conventional PCR, the total sensitivity of identifying a male fetus was 95%, but its sensitivity after the 7th week was 100%, whereas in real-time quantitative PCR, the total sensitivity after the 5th week was 100%. Quantitative analyses of the SRY gene revealed that the mean concentration of fetal DNA in maternal serum was 30.55 copies/ml, that fetal DNA concentration showed a tendency to increase with the progression of pregnancy, and that it had a wide normal range. Thus, we could confidently determine fetal gender by using maternal serum samples taken as early as the 7th week.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 18 条
[1]  
Honda H, 2001, CLIN CHEM, V47, P41
[2]   High sensitivity of fetal DNA in plasma compared to serum and nucleated cells using unnested PCR in maternal blood [J].
Houfflin-Debarge, V ;
O'Donnell, H ;
Overton, T ;
Bennett, PR ;
Fisk, NM .
FETAL DIAGNOSIS AND THERAPY, 2000, 15 (02) :102-107
[3]   Maternal plasma fetal DNA as a marker for preterm labour [J].
Leung, TN ;
Zhang, J ;
Lau, TK ;
Hjelm, NM ;
Lo, YMD .
LANCET, 1998, 352 (9144) :1904-1905
[4]   Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis [J].
Lo, YMD ;
Tein, MSC ;
Lau, TK ;
Haines, CJ ;
Leung, TN ;
Poon, PMK ;
Wainscoat, JS ;
Johnson, PJ ;
Chang, AMZ ;
Hjelm, NM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (04) :768-775
[5]   DETECTION OF SINGLE-COPY FETAL DNA-SEQUENCE FROM MATERNAL BLOOD [J].
LO, YMD ;
PATEL, P ;
SAMPIETRO, M ;
GILLMER, MDG ;
FLEMING, KA ;
WAINSCOAT, JS .
LANCET, 1990, 335 (8703) :1463-1464
[6]   Presence of fetal DNA in maternal plasma and serum [J].
Lo, YMD ;
Corbetta, N ;
Chamberlain, PF ;
Rai, V ;
Sargent, IL ;
Redman, CWG ;
Wainscoat, JS .
LANCET, 1997, 350 (9076) :485-487
[7]  
Lo YMD, 1999, CLIN CHEM, V45, P184
[8]  
Lo YMD, 1999, CLIN CHEM, V45, P1747
[9]   Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma [J].
Lo, YMD ;
Hjelm, NM ;
Fidler, C ;
Sargent, IL ;
Murphy, MF ;
Chamberlain, PF ;
Poon, PMK ;
Redman, CWG ;
Wainscoat, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (24) :1734-1738
[10]   USE OF URACIL DNA GLYCOSYLASE TO CONTROL CARRY-OVER CONTAMINATION IN POLYMERASE CHAIN-REACTIONS [J].
LONGO, MC ;
BERNINGER, MS ;
HARTLEY, JL .
GENE, 1990, 93 (01) :125-128